BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16500393)

  • 21. Severe and steroid-resistant Crohn's disease.
    Michetti P; Mottet C; Juillerat P; Pittet V; Felley C; Vader JP; Gonvers JJ; Froehlich F
    Digestion; 2007; 76(2):99-108. PubMed ID: 18239400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the clinical use of infliximab in Crohn's disease.
    Turner SM; Probert CS
    Rom J Gastroenterol; 2003 Mar; 12(1):2-5. PubMed ID: 12673372
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
    Abdelmalek MF; Liu C; Valentine JF
    Am J Gastroenterol; 2007 Jun; 102(6):1333-4. PubMed ID: 17531027
    [No Abstract]   [Full Text] [Related]  

  • 24. The frequency of sister chromatid exchanges in patients with Crohn's disease and the effect of therapy with "anti-tumor necrosis factor" on this frequency.
    Danalioglu A
    Hepatogastroenterology; 2009; 56(91-92):729-33. PubMed ID: 19621692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Dutch guidelines for treatment with infliximab for Crohn's disease.
    Vermeire S
    Neth J Med; 2006; 64(7):210-1. PubMed ID: 16929081
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perianal Crohn's disease (Br J Surg 2004; 91: 801-814).
    Olaison G; Almer S; Anderson P
    Br J Surg; 2004 Oct; 91(10):1381. PubMed ID: 15382098
    [No Abstract]   [Full Text] [Related]  

  • 28. Maintenance infliximab infusions forever?
    Lee SD; Surawicz CM
    Am J Gastroenterol; 2002 Nov; 97(11):2917-8. PubMed ID: 12425570
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of concurrent elemental diet on infliximab treatment for Crohn's disease.
    Tanaka T; Takahama K; Kimura T; Mizuno T; Nagasaka M; Iwata K; Nakano H; Muramatsu M; Takazoe M
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1143-9. PubMed ID: 16824066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local injection of infliximab in the postoperative recurrence of Crohn's disease.
    Biancone L; Cretella M; Tosti C; Palmieri G; Petruzziello C; Geremia A; Calabrese E; Pallone F
    Gastrointest Endosc; 2006 Mar; 63(3):486-92. PubMed ID: 16500402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological therapy in children with inflammatory bowel syndrome (clinical cases)].
    Alieva ÉI
    Eksp Klin Gastroenterol; 2014; (1):110-2. PubMed ID: 25518466
    [No Abstract]   [Full Text] [Related]  

  • 32. Infliximab for severe gastrointestinal bleeding in Crohn's disease.
    Ando Y; Matsushita M; Kawamata S; Shimatani M; Fujii T; Okazaki K
    Inflamm Bowel Dis; 2009 Mar; 15(3):483-4. PubMed ID: 18668673
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
    Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is keeping the colon the ultimate marker of success in ulcerative colitis?
    Nguyen GC; Prather CM
    Gastroenterology; 2009 Oct; 137(4):1204-6. PubMed ID: 19717125
    [No Abstract]   [Full Text] [Related]  

  • 35. Infliximab and the bone in Crohn's disease.
    Kunisaki R; Chaki O; Taguchi T; Sugiyama T; Sugita A
    Aliment Pharmacol Ther; 2005 Mar; 21(6):789-90. PubMed ID: 15771766
    [No Abstract]   [Full Text] [Related]  

  • 36. Infliximab treatment of massive upper gastrointestinal bleeding in gastroduodenal Crohn's disease.
    Kocaman O; Aygün C; Konduk T; Celebi A; Sentürk O; Hülagü S
    Turk J Gastroenterol; 2008 Sep; 19(3):197-8. PubMed ID: 19115158
    [No Abstract]   [Full Text] [Related]  

  • 37. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
    van den Brande JM; Peppelenbosch MP; Hommes DW
    Gastroenterology; 2006 Oct; 131(4):1362-3. PubMed ID: 17030216
    [No Abstract]   [Full Text] [Related]  

  • 38. [Better to start from top?].
    MMW Fortschr Med; 2005 Oct; 147(42):8. PubMed ID: 16281774
    [No Abstract]   [Full Text] [Related]  

  • 39. [Selective TNF-alpha inhibition in Crohn disease. Emergency help in problem cases].
    MMW Fortschr Med; 2001 May; 143(18):52. PubMed ID: 11387713
    [No Abstract]   [Full Text] [Related]  

  • 40. Infliximab is the drug we have been waiting for in Crohn's disease.
    Rutgeerts P
    Inflamm Bowel Dis; 2000 May; 6(2):132-6. PubMed ID: 10833073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.